Breast Cancer Treatment.

Area of Science:

• Oncology
• Women's Health

Background:

• Breast cancer is a leading global cause of cancer death in women.
• Risk assessment tools aid in identifying high-risk individuals for preventative measures.
• Treatment and management strategies are highly dependent on the stage of breast cancer.

Purpose of the Study:

• To outline breast cancer risk assessment and management.
• To detail treatment modalities based on cancer staging.
• To discuss therapeutic options for various stages of breast cancer, including ductal carcinoma in situ and metastatic disease.

Main Methods:

• Review of current breast cancer risk assessment tools.
• Description of treatment phases: preoperative, surgical, and postoperative.
• Categorization of treatment options by cancer stage and receptor status (ER, PR, ERBB2).

Main Results:

• Ductal carcinoma in situ (DCIS) treatment involves surgery and potentially endocrine therapy.
• Non-metastatic invasive breast cancers (Stages I-III) involve multi-phase treatment including systemic therapies, surgery (lumpectomy or mastectomy), and adjuvant treatments.
• Metastatic (Stage IV) breast cancer is manageable, focusing on improving quality and length of life.

Conclusions:

• Risk stratification is crucial for preventative interventions.
• A multi-modal, stage-specific approach is essential for effective breast cancer treatment.
• Ongoing research and tailored therapies offer improved outcomes for breast cancer patients.